Literature DB >> 22814431

Selection and characterisation of guanidine-resistant mutants of human enterovirus 71.

Sara Sadeghipour1, Emily J Bek, Peter C McMinn.   

Abstract

The replication of human enterovirus 71 (HEV71) in cell culture is inhibited by concentrations of guanidine that do not have an observable adverse effect on host cell metabolism. Although the HEV71 non-structural protein 2C is known to play an important role in viral RNA replication, its precise biochemical activities and structure have not been fully determined. Here we describe amino acid substitutions in HEV71 protein 2C that confer resistance to guanidine. Three guanidine-resistant virus populations were independently isolated and found to contain five mutations in protein 2C, one of which, A4657T (2C-M193L), was present in two of the independently selected populations. This mutation was introduced into a HEV71 infectious cDNA clone and was sufficient to confer complete resistance to growth inhibition in the presence of 4mM guanidine. In the first guanidine-resistant population selected, the 2C-M193L mutation occurred in association with an additional mutation, A4459G (2C-I127V), located in the putative cis-acting replication element (cre) of coding region 2C. This mutation conferred only partial guanidine resistance when introduced into the HEV71-26M infectious clone. When the 2C-I127V and 2C-M193L mutations were introduced into HEV71-26M together, the 2C-I127V mutation did not increase the level of guanidine resistance due to the 2C-M193L mutation alone. This study confirms that guanidine resistance can be readily selected in HEV71 and is attributable to mutations within protein 2C.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22814431     DOI: 10.1016/j.virusres.2012.07.005

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  13 in total

1.  Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in mice.

Authors:  Brett L Hurst; W Joseph Evans; Donald F Smee; Arnaud J Van Wettere; E Bart Tarbet
Journal:  Virology       Date:  2018-10-31       Impact factor: 3.616

2.  Enterovirus D68 Antivirals: Past, Present, and Future.

Authors:  Yanmei Hu; Rami Musharrafieh; Madeleine Zheng; Jun Wang
Journal:  ACS Infect Dis       Date:  2020-05-14       Impact factor: 5.084

3.  Biochemical and structural characterization of hepatitis A virus 2C reveals an unusual ribonuclease activity on single-stranded RNA.

Authors:  Pu Chen; Justyna Aleksandra Wojdyla; Ombretta Colasanti; Zhijian Li; Bo Qin; Meitian Wang; Volker Lohmann; Sheng Cui
Journal:  Nucleic Acids Res       Date:  2022-08-10       Impact factor: 19.160

4.  Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds.

Authors:  Donald F Smee; W Joseph Evans; K C Nicolaou; E Bart Tarbet; Craig W Day
Journal:  Antiviral Res       Date:  2016-04-07       Impact factor: 5.970

5.  Ribavirin-resistant mutants of human enterovirus 71 express a high replication fidelity phenotype during growth in cell culture.

Authors:  Sara Sadeghipour; Emily J Bek; Peter C McMinn
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

6.  Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice.

Authors:  Tao Meng; Jimmy Kwang
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

7.  Experimental adaptation of human echovirus 11 to ultraviolet radiation leads to resistance to disinfection and ribavirin.

Authors:  Anna Carratalà; Hyunjin Shim; Qingxia Zhong; Virginie Bachmann; Jeffrey D Jensen; Tamar Kohn
Journal:  Virus Evol       Date:  2017-11-20

8.  Guanidine hydrochloride reactivates an ancient septin hetero-oligomer assembly pathway in budding yeast.

Authors:  Courtney R Johnson; Marc G Steingesser; Andrew D Weems; Anum Khan; Amy Gladfelter; Aurélie Bertin; Michael A McMurray
Journal:  Elife       Date:  2020-01-28       Impact factor: 8.140

Review 9.  Replication and Inhibitors of Enteroviruses and Parechoviruses.

Authors:  Lonneke van der Linden; Katja C Wolthers; Frank J M van Kuppeveld
Journal:  Viruses       Date:  2015-08-10       Impact factor: 5.048

Review 10.  Recent developments in antiviral agents against enterovirus 71 infection.

Authors:  Chee Wah Tan; Jeffrey Kam Fatt Lai; I-Ching Sam; Yoke Fun Chan
Journal:  J Biomed Sci       Date:  2014-02-12       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.